Deep Genomics Stock

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.

Sign up today and learn more about Deep Genomics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Deep Genomics Stock

The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.

Funding History

November 2015$3.7M
September 2017$13.0M



Hannes Bretschneider

Research Scientist & Engineer

Alice Gao


Hui Yuan Xiong


Andrew Delong

Co-Founder and CEO

Brendan Frey


strictlyvc - Feb, 20 2017

StrictlyVC: November 19, 2015

TechCrunch - Jan, 10 2016

Investing In Artificial Intelligence

genomeweb - Dec, 1 2015

Deep Genomics Raises $3.7M

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: